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Abstract: High prevalence of intestinal amoebiasis is commonly reported by microscopy in Gaza.To determine the 
misdiagnosis of intestinal amoebiasis associated with microscopic examination of faces, two tests were applied: 1-a 
non-specific antigen Entamoeba (ELISA) to differentiate Entamoeba histolytica/Entamoeba dispar complex from 
other non-pathogenic intestinal amoebae.2- An enzyme-linked immunosorbent assay (ELISA) for detecting antibody 
against E. histolytica, 53 stool and serum samples were used in this study: 32 (60.38%) samples were symptomatic 
(diarrheal) patients and 21 (39.62%) were asymptomatic. Data from these two immunological diagnostic tests were 
compared with those obtained by microscopic examination. A routine microscopic examination detected 7(13.25) 
prevalence of Giardia lamblia, 21(39.6%) prevalence of Entamoeba spp. 13(40.6%; X2=0.578; P-value= 0.749) in 
symptomatic stool samples and 8(38.1%) in asymptomatic stool samples. ELISA antigen detected only 2(6.2%; 
X2=1.364; P-value= 0.243) prevalence of E. histolytica/ dispar complex in symptomatic samples and none in 
asymptomatic samples. The two positive symptomatic samples by ELISA/Ag were also positive by microscopy, and 
no negative subject by microscopy was positive by ELISA. ELISA antibody detected 4 (7.5%; X2=0.195; P-value= 
0.659) prevalence of E. histolytica in all subjects: 2(6.2%) in symptomatic samples which were positive by both 
microscopy and ELISA antigen and 2(9.5%) in asymptomatic samples, that were negative by both microscopy and 
ELISA antigen. The ratio of E. histolytica/ dispar was very low (3.7%) suggesting that the vast majority of 
Entamoeba infections in this area were nonpathogenic. The microscopic examination is less sensitive than both 
ELISA/Ag and ELISA/IgG tests. 
[Fayez Muhammad Shaldoum, Nahla Mezeid and Adnan I. Al-Hindi Immune-detection of Entamoeba histolytica 
in symptomatic and asymptomatic infection. J Am Sci 2015;11(5):55-61]. (ISSN: 1545-1003). 
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1. Introduction 
Gaza Strip is one of the most over populated 
areas in the world. The population density in Gaza 
Strip is estimated at 3.867/km2 out of the total area of 
Gaza Strip 364km2 (Human Development Report, 
1997). 
Various microscope investigations have been 
carried out to determine the prevalence of intestinal 
parasite infections in Gaza. Most of the data of 
prevalence were obtained from school and pre-school 
children; Pre-school children from Al-Shatei refugee 
camp children (48%); children from Gaza (27.6%); 
children from Deir El-Balah (36.3%); children from 
Beit-lahia (72.9%), (Al-Wahaidi, 1997; Yassin et al., 
1999; Al-Hindi, 2002; AL-Zain and Al-Hindi, 2005). 
Just one study was carried out using molecular PCR 
(Adnan, 2005) revealed (69%) infection with 
Entamoeba histolytica to be considered the most 
common parasitic causes of acute diarrhea in Gaza. 
Enteric parasites are the most common causes of 
parasitic diseases, and they cause significant 
morbidity and mortality, particularly in endemic areas 
(WHO, 2004). Children and young adults are the most 
affected group, particularly in regions with limited 
resources and in areas which have low hygienic 
measures (Guerrant et al., 2005). 
Amoebiasis is a significant health problem 
worldwide, especially in developing countries. It is 
presently one of the three most common causes of 
death. An estimated 40,000-100,000 people die of 
invasive amoebiasis annually (Stanley, 2003). It has 
also been estimated that, approximately 500 million 
individuals are infected with E. histolytica each year 
and only about 10% experience symptomatic disease 
(Trol et al., 1997 and Haque et al., 1998). 
Although the distribution of the parasite is 
worldwide, the preponderance of morbidity and 
mortality is experienced in Central and South 
America, Africa, and India (Parija et al., 2014). 
Amoebiasis is defined as asymptomatic, invasive 
intestinal or extraintestinal disease due to E. 
histolytica infection. Asymptomatic cyst is the most 
frequent manifestation of intestinal Entamoeba 
infection and 90% of E. histolytica infections are 
asymptomatic (WHO, 1997). 
The genus Entamoeba contains many species, 
some of which (i.e. E. histolytica, E. dispar, E. 
moshkovskii, E. polecki, E. coli and E. hartmanni) can 
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be found in human stools (Clark et al., 1991 and 
Debnath et al., 2004). E. histolytica, thus far, is the 
only species associated with disease (WHO 1997; 
Petri and Singh, 1999 and Haque, 2006). It is 
generally accepted that, E. histolytica actually 
comprises two genetically distinct but 
morphologically indistinguishable species. E. dispar 
has never been documented to cause colitis or liver 
abscess, but is responsible for many cases of 
asymptomatic infection. Identification and 
differentiation of E. histolytica and E. dispar in stool 
samples by microscopy is imprecise. False-positive 
results occur as a result of both pathogenic/non-
pathogenic indiscrimination and identification of 
leukocytes, macrophages and other amoebas as E. 
histolytica in stool (Kebede et al., 2004). 
Compared to the sensitivities of Enzyme-linked 
immunosorbent assay (ELISA) antigen in stool and 
the traditional PCR, real-time PCR has proven to be 
the most sensitive test for the detection of E. 
histolyticain stool (Braga et al., 1998; Haque et al., 
1998; Leo et al., 2006 and Uyar et al., 2009). Real-
time PCR is not easy for routine diagnosis because it 
requires expensive equipment and specialized 
personnel for analysis of the results. For this reason, 
antigen and antibody detection by ELISA is becoming 
the standard method for diagnosis of E. histolytica 
infection (Haque et al., 2006). 
The main objective of our study is to measure the 
specificity and sensitivity of ELISA technique for 
detection of amoebic antigen E. histolytica/ dispar in 
stool samples and IgG antibody E. histolytica in serum 
compared with microscopic diagnosis in both 
symptomatic and asymptomatic individual in Gaza 
Strip. 
2. Subjects and Methods 
Population: 
The study was conducted using random sampling 
among outpatients at hospitals in Gaza Strip. A total 
of 53 stool samples were collected from patients aged 
between 5 and 34 years old. 32 patients visiting the 
hospital for reasons of diarrhea or other 
gastrointestinal symptoms and 21 subjects had no 
diarrhea illness (asymptomatic). 
Ethical consideration: 
1-An approval was obtained from the Ministry of 
Health dated before the commencement of the study. 
2-Informed consent, Patients were asked to participate 
voluntarily after clear explanation. 
Collection of Stool Samples: 
From each subject approximately 10 g of fresh 
stool was taken using a wooden spatula ensuring that 
the sample was not contaminated with urine or water 
in a clean sterile screw disposable plastic container 
labeled clearly with child name, gender, age, address 
and date of collection. The collected stool samples 
were divided into two parts: The first part of the 
specimen was preserved at -20ºC to be used later, 
while the second part was processed immediately for 
microscopic examination. 
Blood Samples: 
Blood samples were collected from subjects; a 
sample of blood consisting of 2 milliliters was 
obtained from anticubital and/or jugular vein by a 
sterile disposable syringe from each subject. The 
blood sample was poured into clean test tube without 
anticoagulant and left for 2-3 minutes in water bath 
(37ºC), then centrifuged at 3000 rpm for 6-10 minutes. 
The serum was separated and transferred to label 
multiple clean Eppendrof tubes with subject full 
information then stored at -20ºC.  
Parasitological methods 
1- Microscopic Examination: 
The stool samples were collected from patients 
in wide-mouthed, screw-capped, labeled containers. 
Primary detection of cysts and ova were made by the 
examination of a wet preparation taken from fresh 
stool. The formalin ether sedimentation technique was 
used (WHO, 1994). 
2-Enzyme-linked immunosorbent assay (ELISA): 
1- ELISA for detection of E. histolytica/ dispar 
antigen in stools. The RIDASCREEN® Entamoeba 
(R-Biopharm AG, Darmstadt, Germany, C1701) 
commercial kit, designed to detect Entamoeba sensu 
lato antigen qualitatively in stool samples, was used 
for antigen detection in stool samples according to the 
manufacturer’s instructions. 2- ELISA for detection of 
IgG antibodies against E. histolytica in human serum. 
The RIDASCREEN® E. histolytica IgG (R-Biopharm 
AG, Darmstadt, Germany, K1721) test is an enzyme 
immunoassay for the qualitative determination of IgG 
antibodies against E. histolytica in human serum. Test 
was also performed according to manufacturer’s 
instructions. 
Statistical Analysis 
The data was analyzed using Statistical Package 
for Social Sciences for Windows, version 17 (SPSS 
Inc., Chicago. IL, USA). Chi-square analyses were 
used to investigate the association between dependent 
and independent variables. Differences were 
considered significant at p>0.05. 
The validity indications used for the detection of 
antibody in sera and antigens in stool samples were 
sensitivity, specificity and positive predictive value 
(PPV) and negative predictive value (NPV). The 
indicators were calculated according to following 
author (Kanchanaraksa, 2008). 
3. Results 
Fecal and serum samples of 53 patients were 
collected from a Gaza Strip. About 32 (60.38%) 
samples were found symptomatic (diarrheal) patients 
and 21 (39.62%) were asymptomatic. 
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Of the symptomatic group, the microscopic 
examination of the fecal sample has revealed: 14 
(43.8%) clean subjects, 13(40.6%) infected with 
Entamoeba species and 5(15.6%) infected with 
Gardia lamblia. The detection of E. histolytica/ dispar 
antigens (Ag) in the fecal samples by ELISA has 
shown 30(93.8%) samples negative to Ag of E. 
histolytica/ dispar and 2(6.2%) positive samples. The 
examination of the serum samples for IgG of E. 
histolytica using ELISA has also resulted in 
30(93.8%) negative and 2(6.2%) positive samples for 
E. histolytica IgG (Table 1). 
The asymptomatic group, the microscopic 
examination of the fecal sample has revealed: 11 
(52.40%) clean subjects, 8 (38.10%) infected with E. 
spp., and 2 (9.50%) infected with G. lamblia. The 
detection of Ag of E. histolytica/ dispar in the fecal 
samples by ELISA has shown that all subjects were 
negative. The examination of the serum samples for 
IgG of E. histolytica using ELISA has also resulted in 
19 (90.50%) negative and 2 (9.50%) positive subjects 
for E. histolytica IgG (Table 1). 
In total 53 samples were examined; 21(39.6%) 
were positive for Entamoeba spp. and 7(13.2%) for G. 
lamblia by microscopy. ELISA/Ag test confirmed 2 
(3.7%) stool samples positive for E. histolytica / 
dispar, while ELISA/IgG detected 4 (7.5%) positive 
samples (Tables 2, 3). 
The microscopic examination, the detection of 
ELISA/Ag of E. histolytica/ dispar complex in stool 
samples and the detection of E. histolytica IgG in 
serum samples regarding E. histolytica infection were 
compared in both symptomatic and asymptomatic 
subjects. In microscopic examination of symptomatic 
patients: 13(40.6%) were infected with Entamoeba 
spp., 5 (15.6%) with G. lamblia and 14 (43.8%) were 
clean, while in asymptomatic subjects 8 (38.1%) were 
infected with E. sp., 2 (9.5%) with G. lamblia and 11 
(52.4%) were clean (X2= 0.578 and P-value= 0.749). 
In ELISA/Ag test of symptomatic patients 30 (93.8%) 
were negative and 2 (6.2%) were positive, while all 
asymptomatic subjects were negative (X2= 1.364 and 
P-value= 0.243). For ELISA/IgG test, 30 (93.8%) 
were negative and 2 (6.2%) were positive in 
symptomatic patients, while 19 (90.5%) were negative 
and 2 (9.5%) were positive in asymptomatic clean 
subjects (X2= 0.195 and P-value= 0.659), Table 1 
and Figure 1. 
The sensitivity and specificity of test, microscopy 
has 9.5% sensitivity and 100% specificity in 
comparison with ELISA/Ag, the positive predictive 
value (PPV) was 100% and negative predictive value 
(NPV) was 62%. ELISA/Ag revealed a sensitivity of 
100% and the specificity of 62.7% compared with 
microscopy. The PPV was 9.5% and NPV was 100%. 
ELISA/ IgG test revealed a sensitivity of 50%, the 
specificity of 61.2%, the PPV was 6.2% and a NPV 
was 93% compared with microscopy, Tables 2 and 3. 
 
Table 1: Comparison between symptomatic and asymptomatic group regarding; microscopy, ELISA/Ag in stool and 
ELISA/IgG in serum test results. 
Parameters 
Symptomatic patients Asymptomatic patients Chi-square test 
No. % No. % X2 P-value 
Microscopy 
Entamoeba spp. 13 40.60% 8 38.10% 
0.578 0.749 G. lamblia 5 15.60% 2 9.50% 
-ve 14 43.80% 11 52.40% 
ELISA /Ag 
-ve 30 93.80% 21 100.00% 
1.364 0.243 
+ve 2 6.20% 0 0.00% 
ELISA /IgG 
-ve 30 93.80% 19 90.50% 
0.195 0.659 
+ve 2 6.20% 2 9.50% 
 
Table 2: Comparison of all Entamoeba histolytica/dispar samples detected using microscopy and ELISA/Ag stool 
samples. 
 ELISA/Ag + ELISA/ Ag - Total 
Microscopy + 2 (100%) 19 (37.3%) 21 (39.6%) 
Microscopy - 0 (0%) 32 (62.7)% 32 (60.4%) 
Total 2 (100%) 51 (100%) 53 (100%) 
 
Table 3: Entamoeba histolytica samples detected by microscopy and ELISA/IgG serum sample. 
 ELISA/ IgG + ELISA/ IgG - Total 
Microscopy + 2 (50%) 19 (38.8%) 21 (39.6%) 
Microscopy - 2 (50%) 30 (61.2%) 32 (60.4%) 
Total 4 (100%) 49 (100%) 53 (100%) 




















Fig. 1: Comparison between symptomatic and asymptomatic groups regarding; microscopy (X2=0.578; P-





The high percentage (39.6%) of individuals 
infected with amoeba was found as expected. It is 
known that prevalence of amoebiasis in Gaza Strip 
communities is high as the diagnosis performed by a 
single microscope stool examination. 
Microscopic examination remains the gold 
standard method for diagnosing intestinal Entamoeba 
infection; however, it cannot differentiate between E. 
histolytica, E. dispar and E. moshkovskii. 
Morphologically, E. polecki, E. coli and E. hartmanni 
can be differentiated from E. histolytica but some of 
their diagnostic morphologic features overlap 
depending on the quality of the smears, creating issues 
for the differential diagnostic identification. 
Additionally, accurate diagnosis of intestinal parasites 
is mostly dependent on the level of expertise of the 
microscopist (Ravdin, 1994 and Leoet al., 2006). 
The sensitivity of microscopy ranged from 10-
60% in the best conditions and presence of leukocytes 
or non-pathogen species in feces can lead to false 
positive results (Garcia and Bruckner,1997).Other 
researchers suggest that microscopic examination of 
the stool is sufficient to diagnose E. histolytica in the 
presence of characteristic microscopic findings 
(Stanley, 2003). 
The present work represents, for the first time in 
Gaza, the use of commercially antigen detection kit to 
estimate the proportions between E. histolytica/E. 
dispar in addition to routine microscopy. Also the IgG 
kit was used to detect specifically the proportions of 
E. histolytica prevalence. Using microscopy, 
21(39.6%) subjects were suspected to be positive for 
E. sp., of which 13(40.6%) were symptomatic patients 
and 8(38.1%) were asymptomatic. Theseresults agree 
with the general microscopic prevalence in Gaza 
which is ranged from 24%-53% in different localities 
(Yassin et al., 1999 and Al-Hindi, 2009). 
Using Entamoeba ELISA antigen (ELISA/Ag) 
kit, it was found that only 2 (3.7%) symptomatic 
patients were positive for E. histolytica/E. dipar 
complex and the same subjects were also positive by 
microscopy. None of asymptomatic subjects were 
found to be positive for the same parasites. The results 
of ELISA/Ag revealed that all the positive samples by 
microscopy, except two samples, were negative by 
ELISA test. Also, none of the negative samples by 
microscopy were found to be positive by 
ELISA/Antigen. 
The difference between microscopy and 
ELISA/Ag test may be attributed to the quantity of the 
pathogen in stools with a low number of cysts; 
according to the manufacturer of the ELISA kit some 
specimens may give weak reactions that are 
inconclusive (Gonin and Trudel 2003). Also, the 
quantity of small cysts of E. coli and large cysts of E. 
hartmanni was probably misdiagnosed as E. 
histolytica/E. dispar in the direct microscopy (Ravdin, 
1994). 
There haven’t been yet studies reported in Gaza 
Strip where ELISA antigen detection method had been 
used to diagnose amoebiasis to compare with the data 
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in this study. One study using molecular techniques 
was done by (Adnan et al., 2005); 92 positive stool 
specimens by microscopy, E. histolytica was 64 
(69.6%) and of E. dispar was 21 (22.8%) when 
examined by PCR. Mixed infection with E. histolytica 
and E. dispar was evident in 7 specimens (7.6%). 
These percentages are considered very high compared 
to the data presented in this study. 
In a similar to this study, the prevalence of 
infection of E. histolytica using antigen detection tests 
was reported to be 4.7% in a survey conducted with 
680 asymptomatic children aged 2-5 years in 
Bangladesh (Haque et al., 1999). Another similar 
studyin Ismailia (Egypt) showed that out of 50 stool 
samples of patients supposed to be E. histolytica by 
microscopy, E. histolytica alone was detected in only 
5 (10%) samples and in association with E. dispar in 8 
(16%) samples by using PCR. On the other hand, 20 
samples (40%) were E. dispar. The other 17 samples 
were negative. E. coli and E. hartmanni were 
commonly misdiagnosed as E. histolytica (Rayan, 
2005). 
A study was conducted in Northeastern Brazil, 
4.1% prevalence rate was obtained with microscopy 
for E. histolytica/E. dispar but with both PCR and 
ELISA, the prevalence of E. histolytica was 0% 
(Sandra, 2004). In Ghana, (Jacoet al., 2003) found a 
high prevalence 98 (39.8%) of the E. histolytica/E. 
dispar complex with microscopy, but they identified 
by PCR only one E. histolytica case. On the other 
hand, (Gonin and Trudel, 2003) found that ELISA/Ag 
was less sensitive than microscopy and PCR in 
differentiating E. histolytica and E. dispar in stool 
samples. 
In the present work, ELISA/Ag test revealed a 
sensitivity of 100% and the specificity of 62.7%. The 
PPV was 9.5% and a NPV was 100%. This result 
agrees with (Barwari and Ismael 2011) that have 
found by ELISA/Ag test a sensitivity of 98.7% and 
specificity of 58.3% compared with microscopy. But, 
this test has no ability to differentiate between E. 
histolytica and E. dispar. This technique can be used 
as an additional standard for diagnosis, epidemiology, 
and quality control for amoebic infections. 
In the present study, microscopy has 9.5% 
sensitivity and 100% specificity in comparison with 
ELISA/Ag. Delialioglu et al.(2004) found that 
microscopy had low sensitivity and high specificity in 
comparison with ELISA, which is similar to this 
study. 
The overall rate of seropositivity among all 
groups for IgG antibodies was 4(7.5%), only 2 (6.2%) 
of the symptomatic individuals that were positive by 
microscopy and ELISA/Ag were seropositive and 
2(9.5%) of the asymptomatic individuals were 
seropositive but they were negative by microscopy 
also by ELISA/Ag. This suggests that individuals may 
have been infected before and recovered from 
infection (Haque et al., 2000). 
The seropositivity rate was higher than the rate 
of ELISA antigen infection because antibodies were 
demonstrated to persist for at least one year (Abd-Alla 
et al., 2002). Although the ELISA/Ag result can't 
differentiate between E. histolytica and E. dispar, 
serologic result ELISA/IgG reflects the incidence of 
E. histolytica infection because E. dispar does not 
show a positive serologic test result (Petri, 1996 and 
Abd-Alla et al., 1998). 
The presence of G. lamblia, that was found in 7 
specimens negative to E. histolytica/E. dispar by both 
microscopy and Entamoeba ELISA, indicated that G. 
lamblia did not cross-react with E. histolytica in the 
ELISA/Ag and ELISA/IgG methods. Other studies 
also reported an absence of cross reaction with non- E. 
histolytica intestinal parasites (Grundy, 1982; Randall 
et al., 1984 and Haghighi and Rezaeian, 2005). 
In the present study the E. histolytica ELISA/ 
IgG test revealed a sensitivity of 50%, the specificity. 
of 61.2%, the PPV was 6.2% and a NPV was 93%. 
Anti-amoebic antibodies develop at the end of a week 
following exposure in symptomatic patients and 
persist for years (Petri and Singh, 1999 and Ravdin, 
2000). 
The results of this study highlight the importance 
of accurate identification of Entamoeba species. In the 
diagnosis of amoebiasis, a simple detection by 
microscopy is not sufficient cause for clinical 
treatment. However, techniques such as ELISA 
detection, described here, should be used for complete 
identification at the species level of parasites. It is 
extremely important for exact diagnosis and for 
providing correct epidemiological data to have a 
precise identification of Entamoeba species. Accurate 
diagnosis of amoebiasis is crucial in order for 
physicians to prescribe proper treatment. These results 
present important information that will help clinicians 
decide whether to apply an antiamoebic treatment or 
search for a different etiology for the presented 
symptoms. Only the specific detection of E. 
histolytica confirms a diagnosis of amoebiasis, while 
the identification of other nonpathogenic amoebas can 
lead clinical investigators to search for different 
pathologies with similar symptoms that would not be 
considered without this information. Quantitative 
serological data constitute valuable information on the 
endemicity of an area, and the results will gain 
reliability from use of two complementary tests 
instead of one. 
In conclusion, the present study has 
demonstrated that E. histolytica and E. dispar 
infections are very low in Gaza population samples. 
Prospective serious studies are needed to clearly 
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define the epidemiology of E. histolytica infection. 
ELISA tests are inexpensive, yield objective results 
and do not require experienced microscopists and can 
therefore be recommended for screening of stools 
worldwide. Thus, determination of the true prevalence 
of E. histolyticais possible and the use of antiparasitic 
drugs is unnecessary. 
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